Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Intense treatment same as advice & exercise at reducing pain from whiplash

Written by | 5 May 2014

Results of a new trial of treatments for chronic whiplash pain, published in The Lancet, suggest that expensive, intense physiotherapy sessions do not show any additional benefit over a… read more.

ACC 2014 Report: Low-dose clonidine and aspirin in non-cardiac patients at risk for atherosclerotic cardiovascular disease (ASCVD) event: POISE-2 Trials

Written by | 1 May 2014

by Bruce Sylvester – Post non-cardiac surgery treatment with low-dose clonidine increased rates of clinically important hypotension and non-fatal cardiac arrest, researchers from the POISE-2 trial have reported.

ACC 2014 Report: Intra-aortic balloon pump may have broader potential

Written by | 25 Apr 2014

The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say.  One of many uses for the intra-aortic balloon pump is helping… read more.

ACC 2014 Report: ACE Inhibitors better than ARBs in CV patients with diabetes

Written by | 23 Apr 2014

Report from the ACC Annual Scientific Meeting, 29 – 31 March 2014 in Washington.   Angiotensin-converting-enzyme (ACE) inhibitors are associated with reduced mortality and cardiovascular events in patients… read more.

New drug reduces chronic pain in shingles

Written by | 3 Mar 2014

A new drug treatment has been found to be effective against chronic pain caused by nerve damage, also known as neuropathic pain, in patients who have had shingles.

Press Release: Emerging data from CLL10 presented at ASH suggests Levact® (bendamustine) and rituximab as new treatment option for fit elderly CLL patients

Written by | 7 Feb 2014

New interim analysis study findings presented for the first time today at the 55th American Society of Hematology (ASH) Annual Meeting in New Orleans suggest bendamustine and rituximab… read more.

Novel approach helps predict outcomes in heart failure

Written by | 28 Jan 2014

by Bruce Sylvester – Researchers have developed a new method to predicting which patients with heart failure will do well with treatment and which patients will not.

Heart attack damage slashed with micro particle therapy

Written by | 27 Jan 2014

First therapy to target damage after heart attack could transform field.  After a heart attack, much of the damage to the heart muscle is caused by inflammatory cells… read more.

FDA Highlights: Prophylactic anastrozole reduces breast cancer development by 53 percent among high risk women

Written by | 10 Jan 2014

by Bruce Sylvester – Prophylactic use of the breast cancer drug anastrozole for five years reduced by 53% the development of breast cancer in post-menopausal women at high… read more.

Jekyll into Hyde: Breathing auto emissions turns HDL cholesterol from ‘good’ to ‘bad’

Written by | 30 Dec 2013

Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to… read more.

Jekyll into Hyde: Breathing auto emissions turns HDL cholesterol from 'good' to 'bad'

Written by | 30 Dec 2013

Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to… read more.

Novel agent shows promise for non-small cell lung cancer

Written by | 3 Dec 2013

by Bruce Sylvester – Researchers report that an experimental cancer drug which has shown efficacy in  treating melanoma also shows promise  in treating non-small cell lung cancer, a… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.